Expertise in
6
conditions

Dr. John E. Mckinnon

Infectious Disease
University Medical Associates Of The Medical University Of South Carol
171 Ashley Ave, 
Charleston, SC 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
University Medical Associates Of The Medical University Of South Carol
171 Ashley Ave, 
Charleston, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Mckinnon is an Infectious Disease provider in Charleston, South Carolina. Dr. Mckinnon is highly rated in 6 conditions, according to our data. His top areas of expertise are HIV/AIDS, Sepsis, Myelitis, and Severe Acute Respiratory Syndrome (SARS). Dr. Mckinnon is currently accepting new patients.

His clinical research consists of co-authoring 24 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Licenses
Internal Medicine in MI
Hospital Affiliations
Musc Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO

Locations

UNIVERSITY MEDICAL ASSOCIATES OF THE MEDICAL UNIVERSITY OF SOUTH CAROL
171 Ashley Ave, Charleston, SC 29425

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab in a Real-World Setting: United States
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab in a Real-World Setting: United States
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Other, Biological
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Enrollment Status: Completed
Publish Date: July 30, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2/Phase 3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Drug
Study Drug: TJ003234
Study Phase: Phase 2/Phase 3
Pilot Test of Clinical Outcome Assessment Methodology (Primarily the Ordinal Scale of Clinical Improvement) and Other Symptom Assessment Patient-reported Outcomes Scales) and Qualitative Evidence of Content Validity
Pilot Test of Clinical Outcome Assessment Methodology (Primarily the Ordinal Scale of Clinical Improvement) and Other Symptom Assessment Patient-reported Outcomes Scales) and Qualitative Evidence of Content Validity
Enrollment Status: Completed
Publish Date: January 04, 2023
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19
Enrollment Status: Terminated
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

24 Total Publications

Infections in Vasculitis: Can We Create an Epidemic of Change?
Infections in Vasculitis: Can We Create an Epidemic of Change?
Journal: The Journal of rheumatology
Published: October 15, 2024
Similar Doctors
Expertise in
19
conditions
Dr. Kent J. Stock
Infectious Disease | Hospital Medicine
Expertise in
19
conditions
Dr. Kent J. Stock
Infectious Disease | Hospital Medicine

Lowcountry Infectious Diseases PA

1938 Charlie Hall Blvd, Unit B, 
Charleston, SC 
 (5.9 mi)
843-402-0227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kent Stock is an Infectious Disease specialist and a Hospital Medicine provider in Charleston, South Carolina. Dr. Stock is highly rated in 19 conditions, according to our data. His top areas of expertise are Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, Pneumonia, Gastrostomy, and Hip Replacement. Dr. Stock is currently accepting new patients.

Expertise in
8
conditions
Dr. Camelia E. Marculescu
Infectious Disease
Expertise in
8
conditions
Dr. Camelia E. Marculescu
Infectious Disease

University Medical Associates Of The Medical University Of South Carol

171 Ashley Ave, 
Charleston, SC 
 (0.1 mi)
843-792-1414
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Camelia Marculescu is an Infectious Disease provider in Charleston, South Carolina. Dr. Marculescu is highly rated in 8 conditions, according to our data. Her top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Infectious Arthritis, and Myelitis. Dr. Marculescu is currently accepting new patients.

Expertise in
3
conditions
Dr. Eric G. Meissner
Infectious Disease
Expertise in
3
conditions
Dr. Eric G. Meissner
Infectious Disease

University Medical Associates Of The Medical University Of South Carol

171 Ashley Ave, 
Charleston, SC 
 (0.1 mi)
843-792-1414
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eric Meissner is an Infectious Disease provider in Charleston, South Carolina. Dr. Meissner is highly rated in 3 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Myelitis. Dr. Meissner is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mckinnon's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile